Latest LabCorp Stories
SUNNYVALE, Calif., Feb. 28, 2011 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Michael Bates, M.D., has joined the company as Vice President of Oncology Research and Development, reporting to David Persing, M.D., Ph.D. In his new role, Dr.
NASHVILLE, Tenn., Feb. 15, 2011 /PRNewswire/ -- Emdeon Inc.
BRANFORD, Conn., Dec. 15, 2010 /PRNewswire/ -- HistoRx announces that Jack Davis has accepted its invitation to join the Board of Directors. As the former President and CEO of both a diagnostic product company and a laboratory testing company, he is an acknowledged diagnostic industry expert. Mr.
FORT MYERS, Fla., Dec. 13, 2010 /PRNewswire/ -- In the wake of news that Adult Industry Medical Health Foundation (AIM), in Sherman Oaks, CA has been temporarily closed, many adult entertainers find themselves without affordable, reliable and confidential blood test options.
MUNDELEIN, Ill., Sept. 10 /PRNewswire/ -- Sysmex America, Inc.
NEW YORK, Aug. 2 /PRNewswire/ -- Empire BlueCross BlueShield, New York's largest insurer by medical membership, announced today that, effective August 1, 2010, it will significantly expand its HMO and PPO/EPO & Indemnity Reference Laboratory Networks.
ST. LOUIS, July 13 /PRNewswire/ -- Thompson Street Capital Partners announced its sale of DCL Medical Laboratories, LLC (DCL) to North Carolina-based Laboratory Corporation of AmericaÂ® Holdings (LabCorp), a national provider of medical laboratory tests and services.
QUEBEC CITY and WEST CHESTER, PA, April 12 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, has appointed Ms.
SAN DIEGO, Oct. 27 /PRNewswire/ -- XIFIN(TM) Inc., the leading provider of revenue cycle management for diagnostic service providers, announced the addition of Rina Wolf as Vice President of Commercialization Strategies, Consulting & Industry Affairs to the XIFIN team. In this capacity Ms.
- Emitting flashes of light; glittering.